Enseignement et innovations pédagogiques en chimie organique et médicinale 27/06/2023
Joined webinar dedicaded to teaching medicinal chemistry/organic chemistry and pedagogical innovations, to foster training of future researchers in the field in Master, PhD and comfort the place of chemistry in Pharmacy studies. (in French)
- Organizers: Line Bourel (AFECT), Christian Cavé (AECOP), Rebecca Deprez-Poulain (SCT)
- Sponsors: AFECT, AECOP, SCT
Covalent modalities: covalent molecular probes 21/11/2022
The aim of the webinar is to offer an introduction to the recent developments of covalent, activity-based probes and reactive warheads, as well as their use in the search for new ligands for potentially hard-to-drug or “undruggable” targets. The webinar will provide a topical overview of this fast-developing field and its potential impact in modern drug development strategies.
- Organizer: Boris Vauzeilles (SCT & ICSN)
- Sponsors: EDELRIS and COVANT
Enseignement et innovations pédagogiques en chimie organique et médicinale 30/06/2022
Joined webinar dedicaded to teachning medicinal chemistry/organic chemistry and pedagogical innovations, to foster training of future researchers in the field in Master, PhD and comfort the place of chemistry in Pharmacy studies. (in French)
- Organizers: Line Bourel (AFECT), Nicolas Willand (AECOP), Rebecca Deprez-Poulain (SCT)
- Sponsors: AFECT, AECOP, SCT
Nucleos(t)ides as antiviral drugs : past, present and future 06/04/2022
The aim of the webinar is to present the most recent advances on Nucleoside-Derived Antiviral Drugs from currently contributing investigators. Providing an overview of this important class of Antivirals according to their biological target and mode of action, a perspective on the most salient milestones in drug discovery to meet antiviral medical needs, and current examples of hit identification - lead optimization in antiviral drugs.
- Organizers : Maria Duca (SCT) & Olivier Lavergne (SCT)
- Sponsor : Oxeltis
SCT-ELF Joint Webinar 28/06/2021
Coorganised between European Lead Factory (ELF) and the Société de Chimie Thérapeutique SCT, this webinar is fully dedicated to the French drug discovery community. ELF, a collaborative public private partnership project supported by IMI (Innovative Medicine Initiative) 1 (FP7) & 2 (Horizon 2020), is aiming to deliver high quality starting points for your Drug Discovery program.
The webinar wishes to present to colleagues from academic research groups and biotech companies in the field of Drug Discovery how ELF can boost their activities in DD in a win-win situation. Open interactive discussions with experts and testimonies will follow after the presentation.
- Organizers: Brigitte Lesur (Servier & SCT), Rebecca Deprez-Poulain (SCT & Université de Lille, Institut Pasteur de Lille), Daniela Bonora (Lygature), Vera Nies (Lygature).